| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Intestinal Diseases Research Program, Department of Medicine, McMaster University, Hamilton, L8N3Z5, Canada
* To whom correspondence should be addressed. E-mail: akiho{at}intmed3.med.kyushu-u.ac.jp.
Crohn's disease is an idiopathic inflammatory condition. However, little is known about the changes that occur in the muscularis externa, despite the fact that this tissue contributes to motility changes and stricture formation. We characterized immune activity in the muscularis from intestinal segments of Crohn's disease patients and evaluated the role of interleukins-4 and 13 (IL-4 and IL-13) as well as Signal Transducer and Activator of Transcription (STAT) 6 in the contractility of the cultured human intestinal smooth muscle cells. CD3+ve cells (p<0.01) and IL-4 protein (p<0.01) were significantly increased in the muscularis of Crohn's disease patients compared to non-inflamed controls. Pre-incubation of human cultured smooth muscle cells with IL-4 (p<0.001) or IL-13 (p<0.05) significantly enhanced carbachol-induced contraction, and this was significantly inhibited by the STAT6 inhibitor leflunomide (p<0.0001). A similar profile was observed in muscle cells isolated from Crohn's disease patients. Both IL-4 and IL-13 increased specific STAT6-DNA binding in control cells and this was inhibited by anti-STAT6 Ab (p<0.05) or leflunomide (p<0.05). Conclusions: IL-4 and IL-13 mediate the hypercontractility of intestinal muscle via a STAT6 pathway at the level of the smooth muscle cell. The STAT6 pathway may contribute to the hypercontractility of intestinal muscle in Crohn's disease.
This article has been cited by other articles:
|
|
 |
|
  Y. Chiba, M. Todoroki, Y. Nishida, M. Tanabe, and M. Misawa A Novel STAT6 Inhibitor AS1517499 Ameliorates Antigen-Induced Bronchial Hypercontractility in Mice Am. J. Respir. Cell Mol. Biol., November 1, 2009; 41(5): 516 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Hu, F. Li, S. Mahavadi, and K. S. Murthy Upregulation of RGS4 expression by IL-1{beta} in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3{beta} pathway Am J Physiol Cell Physiol, June 1, 2009; 296(6): C1310 - C1320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ihara, P. L. Beck, M. Chappellaz, J. Wong, S. A. Medlicott, and J. A. MacDonald Mitogen-Activated Protein Kinase Pathways Contribute to Hypercontractility and Increased Ca2+ Sensitization in Murine Experimental Colitis Mol. Pharmacol., May 1, 2009; 75(5): 1031 - 1041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Chiba, S. Nakazawa, M. Todoroki, K. Shinozaki, H. Sakai, and M. Misawa Interleukin-13 Augments Bronchial Smooth Muscle Contractility with an Up-Regulation of RhoA Protein Am. J. Respir. Cell Mol. Biol., February 1, 2009; 40(2): 159 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Hu, S. Mahavadi, F. Li, and K. S. Murthy Upregulation of RGS4 and downregulation of CPI-17 mediate inhibition of colonic muscle contraction by interleukin-1 Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1991 - C2000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Vallance, N. Radojevic, C. M. Hogaboam, Y. Deng, J. Gauldie, and S. M. Collins IL-4 gene transfer to the small bowel serosa leads to intestinal inflammation and smooth muscle hyperresponsiveness Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G385 - G394. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
